NCT00434187View on ClinicalTrials.gov

Study to Evaluate Multiple Doses of ERB-041 in Healthy, Female Japanese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2006

Study Completion Date

October 31, 2006

Conditions
Healthy
Interventions
DRUG

ERB-041

Trial Locations (1)

305-0856

Kan-nondai, Tsukuba-shi

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00434187 - Study to Evaluate Multiple Doses of ERB-041 in Healthy, Female Japanese Subjects | Biotech Hunter | Biotech Hunter